Search

Your search keyword '"Kawashima, Kiyotaka"' showing total 12 results
Start Over Author "Kawashima, Kiyotaka" Publication Year Range Last 10 years
12 results on '"Kawashima, Kiyotaka"'

1. Supplementary Table 1 from Unique DNA Methylation Patterns Distinguish Noninvasive and Invasive Urothelial Cancers and Establish an Epigenetic Field Defect in Premalignant Tissue

Author

Wolff, Erika M., primary, Chihara, Yoshitomo, primary, Pan, Fei, primary, Weisenberger, Daniel J., primary, Siegmund, Kimberly D., primary, Sugano, Kokichi, primary, Kawashima, Kiyotaka, primary, Laird, Peter W., primary, Jones, Peter A., primary, and Liang, Gangning, primary

Published
2023
Full Text
View/download PDF

2. Supplementary Figure 2 from Unique DNA Methylation Patterns Distinguish Noninvasive and Invasive Urothelial Cancers and Establish an Epigenetic Field Defect in Premalignant Tissue

Author

Wolff, Erika M., primary, Chihara, Yoshitomo, primary, Pan, Fei, primary, Weisenberger, Daniel J., primary, Siegmund, Kimberly D., primary, Sugano, Kokichi, primary, Kawashima, Kiyotaka, primary, Laird, Peter W., primary, Jones, Peter A., primary, and Liang, Gangning, primary

Published
2023
Full Text
View/download PDF

3. Supplementary Figure 1 from Unique DNA Methylation Patterns Distinguish Noninvasive and Invasive Urothelial Cancers and Establish an Epigenetic Field Defect in Premalignant Tissue

Author

Wolff, Erika M., primary, Chihara, Yoshitomo, primary, Pan, Fei, primary, Weisenberger, Daniel J., primary, Siegmund, Kimberly D., primary, Sugano, Kokichi, primary, Kawashima, Kiyotaka, primary, Laird, Peter W., primary, Jones, Peter A., primary, and Liang, Gangning, primary

Published
2023
Full Text
View/download PDF

4. Supplementary Figure 3 from Unique DNA Methylation Patterns Distinguish Noninvasive and Invasive Urothelial Cancers and Establish an Epigenetic Field Defect in Premalignant Tissue

Author

Wolff, Erika M., primary, Chihara, Yoshitomo, primary, Pan, Fei, primary, Weisenberger, Daniel J., primary, Siegmund, Kimberly D., primary, Sugano, Kokichi, primary, Kawashima, Kiyotaka, primary, Laird, Peter W., primary, Jones, Peter A., primary, and Liang, Gangning, primary

Published
2023
Full Text
View/download PDF

6. Supplementary Figure Legends 1-3 from Unique DNA Methylation Patterns Distinguish Noninvasive and Invasive Urothelial Cancers and Establish an Epigenetic Field Defect in Premalignant Tissue

Author

Wolff, Erika M., primary, Chihara, Yoshitomo, primary, Pan, Fei, primary, Weisenberger, Daniel J., primary, Siegmund, Kimberly D., primary, Sugano, Kokichi, primary, Kawashima, Kiyotaka, primary, Laird, Peter W., primary, Jones, Peter A., primary, and Liang, Gangning, primary

Published
2023
Full Text
View/download PDF

7. Salvage Radiotherapy Versus Hormone Therapy for Prostate-specific Antigen Failure After Radical Prostatectomy: A Randomised, Multicentre, Open-label, Phase 3 Trial (JCOG0401)†

Author

Yokomizo, Akira, primary, Wakabayashi, Masashi, additional, Satoh, Takefumi, additional, Hashine, Katsuyoshi, additional, Inoue, Takahiro, additional, Fujimoto, Kiyohide, additional, Egawa, Shin, additional, Habuchi, Tomonori, additional, Kawashima, Kiyotaka, additional, Ishizuka, Osamu, additional, Shinohara, Nobuo, additional, Sugimoto, Mikio, additional, Yoshino, Yasushi, additional, Nihei, Keiji, additional, Fukuda, Haruhiko, additional, Tobisu, Ken-ichi, additional, Kakehi, Yoshiyuki, additional, and Naito, Seiji, additional

Published
2020
Full Text
View/download PDF

8. Validation of Wireless Power Transfer up to 11kW Based on SAE J2954 with Bench and Vehicle Testing

Author

Schneider, Jesse, primary, Carlson, Richard, additional, Sirota, Jonathan, additional, Sutton, Robert, additional, Taha, Eloi, additional, Kesler, Morris, additional, Kamichi, Kensuke, additional, Teerlinck, Ivo, additional, Abeta, Hiroyuki, additional, Minagawa, Yusuke, additional, Yazaki, Satoshi, additional, Yoon, Uooyeol, additional, Kawashima, Kiyotaka, additional, Muskett, Sam, additional, Bohn, Theodore, additional, Mathar, Sebastian, additional, Mikat, Daniel, additional, Guag, Joshua, additional, Seidman, Seth, additional, and Reitan, Ron, additional

Published
2019
Full Text
View/download PDF

9. Salvage Radiotherapy +/- Hormone Therapy versus Hormone Therapy Alone for Prostate-Specific Antigen Failure after Radical Prostatectomy: A Randomised, Multicentre, Open-Label, Phase 3 Trial (JCOG0401)

Author

Naito, Seiji, primary, Wakabayashi, Masashi, additional, Satoh, Takefumi, additional, Hashine, Katsuyoshi, additional, Inoue, Takahiro, additional, Fujimoto, Kiyohide Fujimoto, additional, Egawa, Shin, additional, Habuchi, Tomonori, additional, Kawashima, Kiyotaka, additional, Ishizuka, Osamu, additional, Shinohara, Nobuo, additional, Kakehi, Yoshiyuki, additional, Sugimoto, Mikio, additional, Yoshino, Yasushi, additional, Fukuda, Haruhiko, additional, Nihei, Keiji, additional, and Tobisu, Ken-ichi, additional

Published
2019
Full Text
View/download PDF

11. [PROSTATE CANCER DETECTION ON INITIAL TRANSRECTAL PROSTATE BIOPSY IN RELATION TO PROSTATE-SPECIFIC ANTIGEN LEVELS].

Author

Makino T, Sakura Y, Goto K, Ichikawa H, and Kawashima K

Abstract

(Objective) The prostate cancer detection rates on initial transrectal ultrasound guided prostate biopsies were investigated and the clinicopathological features of prostate cancer patients were examined. (Methods) A retrospective review was performed. From 2003 to 2015, 2,246 patients received initial prostate biopsy in Tochigi Cancer Center. Prostate cancer detection rates and clinicopathological features of the prostate cancer patients in relation to prostate-specific antigen levels were evaluated. (Results) Of the biopsies, 1,294 cases (57.6%) were diagnosed as prostate cancer. The prostate cancer detection rates were 27.8%, 39.8%, 53.6%, 67.4%, 88.4%, 100% in the groups with PSA levels 0.0-3.0, 3.1-4.0, 4.1-10.0, 10.1-20.0, 20.1-100.0, >100.0 ng/ml, respectively. Of all 1,294 cases in prostate cancer, patients rates with the low risk were 0%, 30%, 22%, 0%, 0%, 0% in the groups with PSA levels 0.0-3.0, 3.1-4.0, 4.1-10.0, 10.1-20.0, 20.1-100.0, >100.0 ng/ml, respectively. (Conclusions) From the results of the prostate cancer detection rates and the low risk rates, it seems difficult to determine diagnosis and treatment of prostate cancer only with PSA values.

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results